BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31218209)

  • 1. A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells.
    Huang P; Sun LY; Zhang YQ
    Anal Cell Pathol (Amst); 2019; 2019():6127169. PubMed ID: 31218209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer.
    Cevatemre B; Erkısa M; Aztopal N; Karakas D; Alper P; Tsimplouli C; Sereti E; Dimas K; Armutak EII; Gurevin EG; Uvez A; Mori M; Berardozzi S; Ingallina C; D'Acquarica I; Botta B; Ozpolat B; Ulukaya E
    Pharmacol Res; 2018 Mar; 129():500-514. PubMed ID: 29197639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway.
    Liu Y; Ren Z; Li X; Zhong J; Bi Y; Li R; Zhao Q; Yu X
    Chem Biodivers; 2019 Aug; 16(8):e1900325. PubMed ID: 31290253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway.
    Liu H; Zhao J; Fu R; Zhu C; Fan D
    PLoS One; 2019; 14(5):e0216759. PubMed ID: 31091245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin.
    Du XX; Li YJ; Wu CL; Zhou JH; Han Y; Sui H; Wei XL; Liu L; Huang P; Yuan HH; Zhang TT; Zhang WJ; Xie R; Lang XH; Jia DX; Bai YX
    Biomed Pharmacother; 2013 Jun; 67(5):417-24. PubMed ID: 23582790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.
    Yousef BA; Guerram M; Hassan HM; Hamdi AM; Zhang LY; Jiang ZZ
    Oncol Rep; 2016 Feb; 35(2):1091-100. PubMed ID: 26718323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABT-263 induces G
    Lin QH; Que FC; Gu CP; Zhong DS; Zhou D; Kong Y; Yu L; Liu SW
    Acta Pharmacol Sin; 2017 Dec; 38(12):1632-1641. PubMed ID: 28713162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells.
    Zhang Y; Wang J; Hui B; Sun W; Li B; Shi F; Che S; Chai L; Song L
    Int J Mol Med; 2019 Mar; 43(3):1382-1394. PubMed ID: 30664149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation.
    Lee Y; Na J; Lee MS; Cha EY; Sul JY; Park JB; Lee JS
    Mol Med Rep; 2018 Nov; 18(5):4281-4288. PubMed ID: 30221728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells.
    Yousef BA; Hassan HM; Guerram M; Hamdi AM; Wang B; Zhang LY; Jiang ZZ
    Biomed Pharmacother; 2016 Apr; 79():112-9. PubMed ID: 27044819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cell-cycle arrest and apoptosis in human cholangiocarcinoma cells by pristimerin.
    Sun JM; Xu HT; Zhao L; Zhang YB; Kang PC; Song ZF; Liu HS; Cui YF
    J Cell Biochem; 2019 Jul; 120(7):12002-12009. PubMed ID: 30825242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pristimerin, a naturally occurring triterpenoid, attenuates tumorigenesis in experimental colitis-associated colon cancer.
    Park JH; Kim JK
    Phytomedicine; 2018 Mar; 42():164-171. PubMed ID: 29655682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium Modulates Autophagy in Esophageal and Colorectal Cancer Cells and Enhances the Efficacy of Therapeutic Agents In Vitro and In Vivo.
    O'Donovan TR; Rajendran S; O'Reilly S; O'Sullivan GC; McKenna SL
    PLoS One; 2015; 10(8):e0134676. PubMed ID: 26248051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinobufagin Promotes Cell Cycle Arrest and Apoptosis to Block Human Esophageal Squamous Cell Carcinoma Cells Growth via the p73 Signalling Pathway.
    Deng X; Sheng J; Liu H; Wang N; Dai C; Wang Z; Zhang J; Zhao J; Dai E
    Biol Pharm Bull; 2019; 42(9):1500-1509. PubMed ID: 31474710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p.
    Li Z; Hu C; Zhen Y; Pang B; Yi H; Chen X
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo.
    Liu L; Zuo LF; Zuo J; Wang J
    Mol Med Rep; 2015 Jul; 12(1):1465-72. PubMed ID: 25816175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH; Pi J; Jin H; Cai JY
    J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral-Mediated Beclin-1 Overexpression Inhibits Cell Proliferation and Induces Autophagy of Human Esophageal Carcinoma Eca109 Cell Xenograft in Nude Mice.
    Zhang J; Dong W
    Recent Pat Anticancer Drug Discov; 2020; 15(1):70-77. PubMed ID: 31823702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK.
    Zhao H; Wang C; Lu B; Zhou Z; Jin Y; Wang Z; Zheng L; Liu K; Luo T; Zhu D; Chi G; Luo Y; Ge P
    Cancer Lett; 2016 Apr; 374(1):136-148. PubMed ID: 26854718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.